Ischemic stroke across sexes: What is the status quo?

Front Neuroendocrinol. 2018 Jul:50:3-17. doi: 10.1016/j.yfrne.2018.05.001. Epub 2018 May 16.

Abstract

Stroke prevalence is expected to increase in the next decades due to the aging of the Western population. Ischemic stroke (IS) shows an age- and sex-dependent distribution in which men represent the most affected population within 65 years of age, being passed by post-menopausal women in older age groups. Furthermore, a sexual dimorphism concerning risk factors, presentation and treatment of IS has been widely recognized. In order to address these phenomena, a number of issue have been raised involving both socio-economical and biological factors. The latter can be either dependent on sex hormones or due to intrinsic factors. Although women have poorer outcomes and are more likely to die after a cerebrovascular event, they are still underrepresented in clinical trials and this is mirrored by the lack of sex-tailored therapies. A greater effort is needed in the future to ensure improved treatment and quality of life to both sexes.

Keywords: Estrogen; Gender; Ischemic stroke; Progesterone; Sex; Sex chromosomes; Sexual dimorphism; Testosterone.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain Ischemia* / epidemiology
  • Brain Ischemia* / physiopathology
  • Brain Ischemia* / prevention & control
  • Clinical Trials as Topic* / standards
  • Female
  • Gonadal Steroid Hormones* / metabolism
  • Humans
  • Male
  • Sex Characteristics*
  • Stroke* / epidemiology
  • Stroke* / physiopathology
  • Stroke* / prevention & control

Substances

  • Gonadal Steroid Hormones